Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5632011

COCCN/C(=N\C#N)NCc1nonc1/C(=N/O)Nc1ccc(F)c(Cl)c1.O=C(O)C(F)(F)F

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.35
IDO1 P14902 3/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
MAPT P10636 2/20 0.34
CASP3 P42574 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
MCHR1 Q99705 1/20 0.34
GRIN1 Q05586 1/20 0.33
GRIN2B Q13224 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14442989 0.95 IDO1 (0.36) SMN1; SMN2IDO1CYP1A2CYP3A4CYP2D6
Trifluoroacetic Acid SCHEMBL5631316 0.91 SMN1; SMN2 (0.34) SMN1; SMN2IDO1CYP1A2CYP3A4CYP2D6
SCHEMBL5632016 0.90 SMN1; SMN2 (0.35) SMN1; SMN2IDO1CYP1A2CYP3A4CYP2D6
Trifluoroacetic Acid SCHEMBL5630925 0.89 SMN1; SMN2 (0.35) SMN1; SMN2IDO1CYP1A2CYP3A4CYP2D6
Trifluoroacetic Acid SCHEMBL4981733 0.88 MAPT (0.46) SMN1; SMN2IDO1MEN1KMT2AMAPT
Trifluoroacetic Acid SCHEMBL5633383 0.88 MAPT (0.46) SMN1; SMN2IDO1MEN1KMT2AMAPT
Trifluoroacetic Acid SCHEMBL5632104 0.87 SMN1; SMN2 (0.38) SMN1; SMN2IDO1CYP1A2CYP3A4CYP2D6
SCHEMBL14442998 0.85 MEN1 (0.34) SMN1; SMN2IDO1CYP1A2CYP3A4CYP2D6
Trifluoroacetic Acid SCHEMBL5632789 0.84 IDO1 (0.37) SMN1; SMN2IDO1CYP1A2CYP3A4CYP2D6
SCHEMBL5630673 0.84 MEN1 (0.39) SMN1; SMN2IDO1CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185165-A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase INCYTE CORPORATION 2007-08-09 US claimed
US-20070185165-A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase INCYTE CORPORATION 2007-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185165-A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase IDO1, IDO2, HNMT SMN1; SMN2 3175/4885IDO1 1/4885CYP1A2 202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.